33.41
price down icon0.51%   -0.17
after-market 시간 외 거래: 33.41
loading
전일 마감가:
$33.58
열려 있는:
$33.37
하루 거래량:
583.04K
Relative Volume:
1.00
시가총액:
$1.87B
수익:
$651.97M
순이익/손실:
$59.71M
주가수익비율:
31.24
EPS:
1.0696
순현금흐름:
$172.03M
1주 성능:
+0.54%
1개월 성능:
+7.22%
6개월 성능:
-14.66%
1년 성능:
+8.65%
1일 변동 폭
Value
$33.18
$34.21
1주일 범위
Value
$32.51
$34.21
52주 변동 폭
Value
$27.05
$40.28

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name
명칭
Supernus Pharmaceuticals Inc
Name
전화
301-838-2500
Name
주소
9715 KEY WEST AVENUE, ROCKVILLE, MD
Name
직원
674
Name
트위터
@Supernus_Pharma
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
SUPN's Discussions on Twitter

SUPN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
SUPN
Supernus Pharmaceuticals Inc
33.41 1.88B 651.97M 59.71M 172.03M 1.0696
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
150.75 67.73B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.31 45.73B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.70 44.38B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.51 18.97B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
298.14 13.73B 2.99B 1.21B 1.13B 25.06

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-19 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2025-01-06 개시 Cantor Fitzgerald Overweight
2024-09-11 다운그레이드 Piper Sandler Overweight → Neutral
2023-01-03 재개 Jefferies Buy
2021-12-01 재개 Jefferies Buy
2021-04-13 업그레이드 Jefferies Hold → Buy
2020-06-16 업그레이드 Piper Sandler Neutral → Overweight
2020-06-15 재개 Jefferies Hold
2019-11-08 다운그레이드 Berenberg Buy → Hold
2019-11-07 다운그레이드 Stifel Buy → Hold
2019-11-06 다운그레이드 Jefferies Buy → Hold
2018-11-12 재확인 B. Riley FBR Buy
2018-01-18 재확인 B. Riley FBR, Inc. Buy
2017-12-28 재확인 B. Riley FBR, Inc. Buy
2017-12-04 업그레이드 Janney Neutral → Buy
2017-11-08 업그레이드 Stifel Hold → Buy
2017-10-19 개시 FBR & Co. Buy
2017-09-19 다운그레이드 Stifel Buy → Hold
2017-07-17 다운그레이드 Piper Jaffray Overweight → Neutral
2017-07-14 개시 Janney Neutral
2017-06-01 업그레이드 Piper Jaffray Neutral → Overweight
2016-07-18 다운그레이드 Northland Capital Outperform → Market Perform
2016-07-18 다운그레이드 Piper Jaffray Overweight → Neutral
2016-02-08 업그레이드 Jefferies Hold → Buy
2015-11-05 재확인 Northland Capital Outperform
2015-10-28 개시 Northland Capital Outperform
모두보기

Supernus Pharmaceuticals Inc 주식(SUPN)의 최신 뉴스

pulisher
Jul 28, 2025

Supernus announces expiration of HSR waiting period for Sage Therapeutics - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Supernus-Sage acquisition clears antitrust hurdle as HSR waiting period expires - Investing.com Australia

Jul 28, 2025
pulisher
Jul 28, 2025

Supernus Pharmaceuticals Announces Expiration of - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

Supernus-Sage $12B Merger Gets Key Regulatory Green Light as Tender Offer Deadline Nears - Stock Titan

Jul 28, 2025
pulisher
Jul 28, 2025

Is Supernus Pharmaceuticals Inc. a growth stock or a value stockMaximize portfolio growth with strategic plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Supernus Pharmaceuticals Inc. as a “Buy”Free Risk Assessment Services - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Supernus Pharmaceuticals Inc. stockMaximize gains with proven stock analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Supernus Pharmaceuticals Inc.Unlock powerful market analysis and alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why is Supernus Pharmaceuticals Inc. stock attracting strong analyst attentionAccess exclusive market insights for free - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Supernus Pharmaceuticals Inc.Accelerated investment success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Can Mixed Fundamentals Have A Negative Impact on Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Current Share Price Momentum? - 富途牛牛

Jul 26, 2025
pulisher
Jul 25, 2025

What institutions are buying Supernus Pharmaceuticals Inc. stock nowBreakthrough stock performance - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Supernus Pharmaceuticals Inc. stock priceDouble or triple returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Supernus Pharmaceuticals Inc. stockRapid wealth creation - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN) - FinancialContent

Jul 24, 2025
pulisher
Jul 24, 2025

What makes Supernus Pharmaceuticals Inc. stock attractive to long term investorsBreakout portfolio performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Supernus Pharmaceuticals Inc. a good long term investmentExtraordinary performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Supernus Pharmaceuticals Inc. Stock Analysis and ForecastStrong return on investment - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Benign Growth For Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Underpins Its Share Price - simplywall.st

Jul 23, 2025
pulisher
Jul 23, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Hold" at Wall Street Zen - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Published on: 2025-07-23 12:28:32 - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Supernus Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 5 - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

Supernus Pharmaceuticals to Announce Second Quarter 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

SUPN SEC FilingsSupernus Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Drug Leader Supernus Pharmaceuticals Sets Q2 2025 Earnings Call with CEO Presentation - Stock Titan

Jul 22, 2025
pulisher
Jul 19, 2025

Supernus Pharmaceuticals Faces 3.2% Share Decline: Sector Challenges ImpactNews and Statistics - IndexBox

Jul 19, 2025
pulisher
Jul 18, 2025

(SUPN) Investment Report - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 18, 2025

Why Supernus Pharmaceuticals (SUPN) Shares Are Falling Today - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Is Supernus Pharmaceuticals Inc. stock a growth or value playQuick Profit Idea Stream - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Holdings Lowered by Teacher Retirement System of Texas - Defense World

Jul 17, 2025
pulisher
Jul 15, 2025

Why Supernus Pharmaceuticals Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Supernus Pharmaceuticals Inc. stock performs during market volatilityStrong Buy Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Supernus Pharmaceuticals Inc. stock price move sharplyFree Stock Market Expert Consultation - Newser

Jul 15, 2025

Supernus Pharmaceuticals Inc (SUPN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$72.41
price down icon 0.71%
$14.58
price down icon 2.28%
$9.26
price down icon 1.59%
drug_manufacturers_specialty_generic RDY
$14.70
price up icon 0.20%
$133.71
price up icon 1.19%
$298.14
price down icon 2.09%
자본화:     |  볼륨(24시간):